IP Library Granted Patent US 11,040,129
Granted Patent B2
US 11,040,129 · App. 16/091,971 · Granted Jun 22, 2021

Mobile continuous ambulatory peritoneal dialysis system

Inventor: Gowrishankar Wuppuluru (Chennai, IN)
A61M1/284A61M1/28A61M1/262A61M1/267A61M2205/3368A61M2205/3372A61M2205/36A61M2205/3653A61M2209/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,040,129
App. No.
16/091,971
Granted
Jun 22, 2021
Kind
B2
Abstract

A wearable mobile continuous ambulatory peritoneal dialysis (mCAPD) system, includes an mCAPD module mounted on a front portion of a wearable belt, wherein the mCAPD module comprises a micro-peristaltic pump disposed in a corresponding front portion, and an electronic control board connected to the micro-peristaltic pump for controlling and managing the mCAPD process, a fluid bag containing a dialysate fluid, attached to the wearable belt and to the electronic control board, and a sterile connector having a tube portion fixed into a guide section of the micro-peristaltic pump, and a first connecting end for connecting to a first tube inserted into a peritoneum cavity of the human body, and a second connecting end for connecting to a second tube attached to the fluid bag. Upon rotation, the micro-peristaltic pump enables a flow of fluid between the peritoneum cavity and the fluid bag.

Claims (31)

1. A wearable mobile continuous ambulatory peritoneal dialysis (mCAPD) system, comprising:

a mCAPD module mounted on a front portion of a wearable belt, wherein the mCAPD module comprises a micro-peristaltic pump disposed in a corresponding front portion, and an electronic control board connected to the micro-peristaltic pump for controlling and managing a mCAPD process;

a fluid bag containing a dialysate fluid, attached to the wearable belt and to the electronic control board; and

a sterile connector having:

a tube portion fixed onto a guide section of the micro-peristaltic pump;

a first connecting end for connecting to a first tube inserted into a peritoneal cavity of the human body; and

a second connecting end for connecting to a second tube attached to the fluid bag,

wherein upon rotation, the micro-peristaltic pump enables a flow of fluid between the peritoneum cavity and the fluid bag, through the tube portion of the sterile connector, and wherein a direction and speed of rotation of the micro-peristaltic pump are controlled by the electronic control board,

wherein the micro-peristaltic pump comprises:

a static base assembly;

a movable assembly for gliding with respect to the static base assembly through a T-slot mechanism; and

a latch configured to release and unlock the movable assembly from the static base assembly, such that during an open position of the latch, the static and movable assemblies slide through one or more T-slots, and a gap created between the static base and movable assemblies allow placement of the sterile connector therebetween.

2. The wearable mCAPD system as claimed in claim 1 , further comprising:

a heating element attached to the fluid bag for heating the dialysate fluid; and

a fluid flow sensor attached to the sterile connector for measuring a quantity of dialysate fluid flowing therethrough, wherein the electronic control board is connected to the heating element for automatically controlling a temperature of the heating element, and connected to the fluid flow sensor for automatically recording a quantity of the dialysate fluid flowing therethrough.

3. The wearable mCAPD system as claimed in claim 2 , wherein the fluid flow sensor is an opto-electronic sensor that generates one or more signals corresponding to one or more hues of color of the dialysate fluid, and wherein the electronic control board automatically analyzes a quality of corresponding dialysis based on the one or more hues of color, and generates one or more alerts in an event of an improper dialysis.

4. The wearable mCAPD system as claimed in claim 1 , wherein the electronic control board comprises:

an input interface for receiving one or more user instructions regarding initiation, timings and durations of one or more dialysis cycles;

a programmable timer mechanism for monitoring timings of fill and drain processes of one or more dialysis cycles based on the one or more user instructions, and generating one or more alerts indicating start and end times of one or more fill and drain processes of the one or more dialysis cycles;

a rechargeable battery for powering the micro-peristaltic pump, and the electronic control board;

an LCD display for displaying a dialysis menu, the one or more user instructions, timing parameters of one or more dialysis cycles, status and duration of one or more dialysis cycles, and the one or more alerts; and

a buzzer for generating one or more audio alerts at predefined intervals for prompting the user to replace the fluid bag.

5. The wearable mCAPD system as claimed in claim 4 , wherein the electronic control board is configured to export one or more records related to dialysis parameters to one or more mobile communication devices.

6. The wearable mCAPD system as claimed in claim 4 , wherein the electronic control board is configured to be interfaced with a mobile communication device through at least one of: WIFI, Bluetooth, and NFC, for enabling the user to operate the wearable mCAPD system through the mobile communication device.

7. The wearable mCAPD system as claimed in claim 1 , wherein the sterile connector includes:

the tube portion for carrying the dialysate fluid;

first and second receiving ends for receiving the first and second tubes; and

the first and second connecting ends for connecting the tube portion to the first and second tubes respectively,

wherein the first receiving and connecting ends are enclosed in a first sterile transparent enclosure, and the second receiving and connecting ends are enclosed in a second sterile transparent enclosure for providing a sterile environment for connecting the first and seconds tubes to the first and second connecting ends respectively.

8. The wearable mCAPD system as claimed in claim 7 , wherein the first and second sterile transparent enclosures are ‘Y’ shaped plastic casings.

9. The wearable mCAPD system as claimed in claim 1 , wherein a filtering device is connected to the sterile connector for receiving and filtering a dialysate fluid extracted from the peritoneal cavity, and providing the filtered fluid back to the peritoneal cavity, to implement a Continuous Flow Peritoneal Dialysis (CFPD) process using the wearable mCAPD system.

Priority Claims (1)
IN 687/CHE/2014 · May 13, 2014 · national
Continuity (1)
Related Publication 20190224400A1 · Jul 25, 2019